Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy(With Syndrome of Yin Deficiency With Internal Heat and Blood Stasis Obstructing the Collaterals of the Eyes)

NCT06817265 is registered in ClinicalTrials.gov with Beletalent (Zhuhai) Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06817265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06817265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy(With Syndrome of Yin Deficiency With Internal Heat and Blood Stasis Obstructing the Collaterals of the Eyes)
Lead sponsor
Beletalent (Zhuhai) Pharmaceutical Co., Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
April 29, 2025
Completion date
December 31, 2026
Enrollment
360 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

non-proliferative diabetic retinopathy